The Effectiveness Of Sorafenib In Newly Diagnosed HCC

The Effectiveness Of Sorafenib In Newly Diagnosed HCC

User Photo
obr

2 years
77 Views
Share
Want to watch this again later?
Sign in to add this video to a playlist. Login
0 0
Category:
Description:
Richard Finn, MD Professor of Clinical Medicine, Department of Medicine, Division of Hematology/ Oncology, Geffen School of Medicine, UCLA discusses The Effectiveness Of Sorafenib In Newly Diagnosed HCC. At The 2019 Gastrointestinal Cancers Symposium In San Francisco, CA On Jan 17, 2019. http://obroncology.com
Up Next Autoplay
>